You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 5, May 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (6)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Multiple Sclerosis/ Demyelinating Disease
 •Radiologic Imaging
 •Magnetic Resonance Imaging
 •Alert me on articles by topic

Magnetization Transfer Magnetic Resonance Imaging and Clinical Changes in Patients With Relapsing-Remitting Multiple Sclerosis

Celia Oreja-Guevara, MD; Arnaud Charil, MSc; Domenico Caputo, MD; Rosella Cavarretta, MD; Maria Pia Sormani, PhD; Massimo Filippi, MD

Arch Neurol. 2006;63:736-740.

Background  Magnetization transfer (MT) magnetic resonance imaging (MRI) can provide in vivo quantitative estimates of microscopic tissue damage in normal-appearing white matter (NAWM) and gray matter (GM) from patients with multiple sclerosis (MS).

Objective  To determine whether a onetime MT MRI can provide markers of short-term disease evolution in patients with relapsing-remitting MS.

Design  Eighteen-month observational study.

Setting  Neuroimaging Research Unit, Scientific Institute and University Ospedale San Raffaele.

Patients  Twenty-two patients with untreated relapsing-remitting MS.

Main Outcome Measures  Relapse rate; disability according to the Expanded Disability Status Scale (EDSS); dual-echo, 2-dimensional gradient echo with and without a saturation MT pulse and T1-weighted MRIs of the brain; and MT ratio (MTR) histograms for NAWM and GM.

Results  During the study period, 13 patients (59%) experienced 25 relapses. The median EDSS score was 1.25 (range, 0-3.5) at study entry and 1.75 (range, 0-3) at study exit. Significant, although moderate, correlations were found between average GM MTR values at baseline and EDSS changes during the study period (r = –0.44; P = .04). A trend was observed for the correlation between NAWM MTR values at baseline and the EDSS changes throughout 18 months (r = –0.42; P = .05). For the relation between EDSS changes and baseline GM MTR, the slope of the regression line was –0.5 (95% confidence interval, –1.0 to 0.0), indicating that a decrease in the baseline GM MTR of 1% predicted an increase in the EDSS score of 0.5 point throughout the 18 months.

Conclusion  This study indicates that a "snapshot" MT MRI assessment detects subtle brain tissue changes that are associated with short-term disability accumulation in patients with relapsing-remitting MS.


Author Affiliations: Neuroimaging Research Unit, Department of Neurology, Scientific Institute and University Ospedale San Raffaele (Drs Oreja-Guevara, Sormani, and Filippi and Mr Charil), and Department of Neurology (Drs Caputo and Cavarretta) and MRI Research Group (Dr Filippi), Fondazione Don Gnocchi, Milan, Italy; and Dipartimento di Scienze della Salute, Biostatistics Unit, University of Genoa, Genoa, Italy (Dr Sormani).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives
Bar-Zohar et al.
Mult Scler 2008;14:719-727.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.